Cogent Biosciences, Inc.COGTNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P16
Within normal range
vs 5Y Ago
-2.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -23.05% |
| Q3 2025 | -17.87% |
| Q2 2025 | 18.00% |
| Q1 2025 | -9.80% |
| Q4 2024 | -16.53% |
| Q3 2024 | -21.74% |
| Q2 2024 | 18.71% |
| Q1 2024 | -19.19% |
| Q4 2023 | -16.06% |
| Q3 2023 | -18.42% |
| Q2 2023 | 18.86% |
| Q1 2023 | -34.38% |
| Q4 2022 | 14.61% |
| Q3 2022 | -30.18% |
| Q2 2022 | 6.63% |
| Q1 2022 | -36.37% |
| Q4 2021 | -47.26% |
| Q3 2021 | -12.77% |
| Q2 2021 | -10.07% |
| Q1 2021 | -21.35% |
| Q4 2020 | 8.78% |
| Q3 2020 | -23.34% |
| Q2 2020 | -5.46% |
| Q1 2020 | 6.54% |
| Q4 2019 | 17.26% |
| Q3 2019 | 10.02% |
| Q2 2019 | 1.51% |
| Q1 2019 | -27.69% |
| Q4 2018 | -19.08% |
| Q3 2018 | 4.27% |
| Q2 2018 | 0.85% |
| Q1 2018 | -22.48% |
| Q4 2017 | -3.59% |
| Q3 2017 | -9.18% |
| Q2 2017 | 20.73% |
| Q1 2017 | 0.00% |
| Q3 2016 | 0.00% |
| Q3 2015 | 0.00% |